Representative Eliot Engel (D-NY, 17th) introduced a resolution (H.Res. 594) titled “Commending the progress made by anti-tuberculosis programs”, which states, among other things, that the House of Representatives “supports the goals of World TB Day to raise awareness about tuberculosis” and “reaffirms its commitment to global tuberculosis control made through the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.”
USAID released a report titled “U.S. Government Report on International Foreign Assistance in TB FY 2010: Leading and Leveraging,” which summarizes U.S. global tuberculosis funding and programs in FY 2010.
The White House released the FY 2013 budget request, which included funding for the U.S. Global Health Initiative (GHI) and other global health activities. Overall, funding for the GHI is down in the FY 2013 request, with most of the reduction coming from HIV/AIDS bilateral amounts. Most other areas saw decreases as well, except for family planning and funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria and GAVI, which increased.
FY12 Estimate (millions)
FY13 Request (millions)
Difference: FY13 – FY12 (millions)
The Global Health Initiative (GHI)
of which PEPFAR
of which HIV*
of which TB
of which Global Fund
*Total USG bilateral funding for HIV/AIDS programs.
The Congressional Research Service (CRS) released a report titled “State, Foreign Operations, and Related Programs: FY2012 Budget and Appropriations”. According to the summary, “[t]his report analyzes the FY2012 request and congressional action related to FY2012 State-Foreign Operations legislation.”
The Congressional Research Service (CRS) released a report titled “U.S. Response to the Global Threat of Tuberculosis: Basic Facts”. According to the report summary, “[t]his report outlines basic facts related to global TB, including characteristics of the epidemic and U.S. legislation, programs, funding, and partnerships related to the global response to TB.”
UPDATE: The President signed the bill into law (Public Law #112-74) on December 23, 2011 after the Conference Agreement passed the House (296-121) on December 16, 2011 and the Senate (67-32) on December 17, 2011. Additionally, the Senate voted against (43-56) a resolution (H.Con.Res. 94) that would have applied a 1.83% across-the-board rescission to all FY 2012 appropriations except the Department of Defense (DoD), Military Construction, and Veterans Affairs.
Representative Hal Rogers (R-KY, 5th; Chairman House Committee on Appropriations) released a statement announcing that a joint House-Senate Conference Committee had reached agreement on final FY 2012 Appropriations legislation (H.R. 2055), which includes funding for global health programs through the State Department, U.S. Agency for International Development (USAID), the Department of Health and Human Services (HHS), and the Department of Defense (DoD). While total funding for the Global Health Initiative (GHI) is not yet available, the appropriations detailed in this agreement totaled $8.3 billion.
Directs that no FY 2012 global health funds may be used for needle exchange programs;
Includes additional Congressional oversight before the Administration makes a multi-year funding pledge;
Requires the Administration to report back to Congress with an analysis of the potential costs/savings of transitioning the Office of the Global AIDS Coordinator (OGAC) into USAID; and
Requires the Administration to report back to Congress with an analysis of transitioning the leadership of the Global Health Initiative (GHI) to USAID as outlined in the Quadrennial Diplomacy and Development Review (QDDR).
Global health appropriations as provided in the Conference Report (House Report 112-331) and Joint Statement of Managers are summarized as follows:
Senator Richard Blumenthal (D-CT) introduced S. 1734 – Generating Antibiotic Incentives Now Act of 2011. The bill provides incentives for the development of “antibiotic drug[s] for treating, detecting, preventing, or identifying a qualifying pathogen,” including, among other infectious agents, multi-drug resistant tuberculosis.
Learn more about the House companion bill (H.R. 2182).
During remarks at the release of the World Health Organization’s (WHO) 2011 Global Tuberculosis Control Report, U.S. Agency for International Development (USAID) Assistant Administrator for Global Health Ariel Pablos-Mendez summarized USAID efforts to combat TB, HIV/TB co-infection, and drug resistant TB through initiatives such as the Global Health Initiative (GHI) and the President’s Emergency Plan for AIDS Relief (PEPFAR).
The Senate Committee on Appropriations released a summary of the FY 2012 State and Foreign Operations Appropriations bill (S.1601, Committee Report) as approved by the full Committee on September 21, 2011. The proposed bill includes funding for the U.S. Global Health Initiative (GHI) of approximately $7.9 billion from the Global Health and Child Survival (GHCS) Account, which is $810.5 million below the President’s FY 2012 budget request of $8.7 billion and $75.69 million above FY 2011 levels of $7.8 billion for the GHCS (additional funding for the GHI is provided through other spending bills). Funding from GHCS for specific areas is as follows:
Maternal & Child Health (MCH): $595 million, of which $35 million is for polio eradication
Neglected Tropical Diseases (NTDs): $89 million
Malaria: $642 million
Tuberculosis: $225 million
HIV/AIDS: $4,850 million
Global Fund: $750 million
The proposed bill also provides for the following:
Family Planning/Reproductive Health: $700 million from all accounts (including the GHCS account), of which $40 million is for the United Nations Population Fund (UNFPA)
Millennium Challenge Corporation (MCC): $898.2 million
Global Agricultural and Food Security Program: $200 million
*These funding amounts are preliminary only and will be updated as more information becomes available.